Skip to main content
    D

    Doximity Inc (DOCS)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $32.79
    -0.55 (-1.65%)

    Market Cap: $5.95B

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Doximity Inc (DOCS) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Doximity (DOCS) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, Doximity reported EPS of $0.19, in line with the $0.19 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    86%(19/22)
    Avg Surprise
    +29.48%

    Upcoming Estimates

    Reports Feb 3, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.44
    Range$0.39 - $0.51
    17 analysts
    EPS Revisions
    12
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.42+5.8%
    60d ago$0.42+6.9%
    30d ago$0.42+6.5%
    7d ago$0.42+6.5%
    Current$0.44
    Revenue Consensus
    $195.53M
    Range$195.00M - $196.20M
    17 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.26
    Range$0.22 - $0.32
    24 analysts
    Revenue Consensus
    $157.52M
    Range$147.15M - $171.99M
    21 analysts

    Next Report

    DOCS has an expected report date of Feb 3, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 4.3% below the $0.46 reported for the quarter ended Dec 31, 2025.

    DOCS Earnings Call

    The latest DOCS earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 22 quarters below that had an estimate, DOCS beat 19, missed 2 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $174.54M, up 3.6% from $168.53M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.19$0.19N/A0.00%In line-57.8%180 up, 1 downNov 5, 2026$174.54M
    Jun 30, 2026$0.14$0.16N/A-12.50%Miss-48.1%180 up, 13 downAug 6, 2026$156.62M
    Mar 31, 2026$0.26$0.28$0.22 - $0.33-7.14%Miss-18.8%190 up, 17 downMay 13, 2026$145.37M
    Dec 31, 2025$0.46$0.45$0.37 - $0.48+2.22%Beat+2.2%193 up, 5 downFeb 5, 2026$185.05M
    Sep 30, 2025$0.45$0.38$0.33 - $0.41+18.42%Beat+50.0%172 up, 0 downNov 6, 2025$168.53M
    Jun 30, 2025$0.27$0.24N/A+12.50%Beat-3.6%164 up, 6 downAug 7, 2025$145.91M
    Mar 31, 2025$0.32$0.20N/A+60.00%Beat+28.0%1714 up, 0 downMay 15, 2025$138.29M
    Dec 31, 2024$0.45$0.34$0.32 - $0.35+32.35%Beat+55.2%1413 up, 0 downFeb 6, 2025$168.60M
    Sep 30, 2024$0.30$0.26$0.23 - $0.27+15.38%Beat+36.4%141 up, 0 downNov 7, 2024$136.83M
    Jun 30, 2024$0.28$0.23$0.20 - $0.24+21.74%Beat+47.4%150 up, 0 downAug 8, 2024$126.68M
    Mar 31, 2024$0.25$0.20$0.14 - $0.22+25.00%Beat+25.0%151 up, 0 downMay 16, 2024$118.06M
    Dec 31, 2023$0.29$0.24$0.16 - $0.25+20.83%Beat+31.8%120 up, 0 downFeb 8, 2024$135.28M
    Sep 30, 2023$0.22$0.18$0.16 - $0.20+22.22%Beat+29.4%90 up, 0 downNov 9, 2023$113.61M
    Jun 30, 2023$0.19$0.15$0.12 - $0.17+26.67%Beat+35.7%100 up, 0 downAug 8, 2023$108.47M
    Mar 31, 2023$0.20$0.17$0.16 - $0.19+17.65%Beat-4.8%100 up, 0 downMay 16, 2023$110.97M
    Dec 31, 2022$0.22$0.17$0.16 - $0.20+29.41%Beat-24.1%90 up, 0 downFeb 9, 2023$115.26M
    Sep 30, 2022$0.17$0.16$0.14 - $0.18+6.25%Beat-10.5%110 up, 0 downNov 10, 2022$102.19M
    Jun 30, 2022$0.14$0.11$0.07 - $0.12+27.27%Beat+27.3%90 up, 1 downAug 4, 2022$90.64M
    Mar 31, 2022$0.21$0.15$0.12 - $0.23+40.00%Beat+250.0%90 up, 0 downMay 17, 2022$93.65M
    Dec 31, 2021$0.29$0.12$0.11 - $0.19+141.67%BeatN/A80 up, 0 downFeb 8, 2022$97.88M
    Sep 30, 2021$0.19$0.09$0.09 - $0.11+111.11%Beat-56.7%6N/ANov 9, 2021$79.35M
    Jun 30, 2021$0.11$0.08$0.06 - $0.10+37.50%BeatN/A6N/AAug 10, 2021$72.67M
    Mar 31, 2021$0.06N/AN/AN/AN/AN/AN/AN/AJun 25, 2021$66.69M
    Dec 31, 2020-$0.09N/AN/AN/AN/AN/AN/AN/AMar 31, 2021$58.71M
    Sep 30, 2020$0.44N/AN/AN/AN/AN/AN/AN/ADec 31, 2020$45.11M
    Dec 31, 2019-$0.33N/AN/AN/AN/AN/AN/AN/AMar 30, 2020$32.43M
    Last 26 quarters

    Annual EPS

    EPS for the fiscal year ended Mar 31, 2026 was $1.44, up 6.7% from the year before. It was $0.08 for the year ended Mar 31, 2021, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Mar 31, 2026$1.44+6.7%
    Mar 31, 2025$1.35+42.1%
    Mar 31, 2024$0.95+30.1%
    Mar 31, 2023$0.73-8.8%
    Mar 31, 2022$0.80+939.0%
    Mar 31, 2021$0.08N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,700 words across 17 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20266,68917
    2026Q2Jun 30, 20268,64820
    2026Q1Mar 31, 20268,45518
    2025Q4Dec 31, 20258,65118
    2025Q3Sep 30, 20259,16723
    2025Q2Jun 30, 20258,08317
    2025Q1Mar 31, 20258,03520
    2024Q4Dec 31, 20245,0369

    2026Q3 Earnings Call

    Opening remarks

    Perry Gold VP of Investor Relations Thank you, operator. Hello, and welcome to Doximity's fiscal 2026 third quarter earnings call. With me on the call today are Jeffrey Tangney, Co-Founder and CEO of Doximity, and audit committee chair and board member, Tim Cabral, who is stepping in to help out with our CFO, Anna Bryson, currently on medical leave. A complete disclosure of our results can be found in our press release issued earlier today as well as in our related Form 8-K. Along with a copy of our prepared remarks, all available on our website at investors.doximity.com. As a reminder, today's call is being recorded and a replay will be available on our website. As part of our comments today, we will be making forward-looking statements. These statements are based on management's current views, expectations, and assumptions and are subject to various risks and uncertainties. Actual results may differ materially, and we disclaim any obligation to update any forward-looking statements or outlook. Please refer to the risk factors in our annual report on Form 10-K, any subsequent Form 10-Qs, and our other reports and filings with the SEC that may be filed from time to time, including our upcoming filing on Form 10-Q. Our forward-looking statements are based on assumptions that we believe to be reasonable as of today's date, February 5, 2026. Of note, it is Doximity's policy to neither reiterate nor adjust the financial guidance provided on today's call unless it is also done through a public disclosure such as a press release or through the filing of a Form 8-K. Today, we will discuss certain non-GAAP metrics that we believe aid in the understanding of our financial results. A historical reconciliation to comparable GAAP metrics can be found in today's earnings release. Finally, during the call, we may offer incremental metrics to provide greater insights into the dynamics of our business. These details may be one-time in nature, and we may or may not provide updates on those metrics in the future. I would now like to turn the call over to our co-founder and CEO, Jeffrey Tangney. Jeff?

    Jeffrey Tangney Co-Founder & CEO Thanks, Perry, and thank you, everyone, for joining our third quarter earnings call. We have four updates today: our CFO, financials, network stats, and AI results. First, some unfortunate news. Our CFO, Anna Bryson, is out sick on medical leave. We miss her here at the office and wish her the best. I know she wishes she could be here too. We've been fortunate to have Tim Cabral, the former ten-year veteran CFO from Viva Systems, as our audit committee chair for the past five years.

    Frequently Asked Questions About DOCS

    When is Doximity's next earnings date?

    Doximity's next earnings report is expected for Feb 3, 2027.

    Did DOCS beat earnings estimates last quarter?

    Doximity reported EPS of $0.19 for the quarter ended Sep 30, 2026, in line with the $0.19 estimate.

    What EPS do analysts expect from DOCS next quarter?

    The consensus EPS estimate for Doximity for the quarter ending Dec 31, 2026 is $0.44 from 17 analysts, with estimates from $0.39 to $0.51.

    How often does DOCS beat earnings estimates?

    Doximity beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +13.23%.